ATE404186T1 - Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden - Google Patents

Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden

Info

Publication number
ATE404186T1
ATE404186T1 AT05791779T AT05791779T ATE404186T1 AT E404186 T1 ATE404186 T1 AT E404186T1 AT 05791779 T AT05791779 T AT 05791779T AT 05791779 T AT05791779 T AT 05791779T AT E404186 T1 ATE404186 T1 AT E404186T1
Authority
AT
Austria
Prior art keywords
particles
preciption
aerosol
suspension aerosol
producing suspension
Prior art date
Application number
AT05791779T
Other languages
English (en)
Inventor
Li Li Bovet
Jay T Holt
Original Assignee
Generics Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics Uk Ltd filed Critical Generics Uk Ltd
Application granted granted Critical
Publication of ATE404186T1 publication Critical patent/ATE404186T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
AT05791779T 2004-10-12 2005-10-12 Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden ATE404186T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61768604P 2004-10-12 2004-10-12

Publications (1)

Publication Number Publication Date
ATE404186T1 true ATE404186T1 (de) 2008-08-15

Family

ID=36001155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05791779T ATE404186T1 (de) 2004-10-12 2005-10-12 Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden

Country Status (8)

Country Link
US (1) US9808423B2 (de)
EP (1) EP1811981B1 (de)
AT (1) ATE404186T1 (de)
AU (1) AU2005293328B2 (de)
CA (1) CA2581999C (de)
DE (1) DE602005009012D1 (de)
ES (1) ES2317306T3 (de)
WO (1) WO2006040598A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
GB0614621D0 (en) * 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
GB2448183A (en) * 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
EP2501363B1 (de) * 2009-11-17 2015-01-14 Cipla Limited Inhalationslösungen
CN109762373B (zh) * 2019-01-21 2020-12-22 济南大学 一种含氟聚合物包覆型球形铝粉及其制备工艺与应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556587A (de) 1957-01-31 1957-04-11
US4352789A (en) 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
ZW6584A1 (en) 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
AU675633B2 (en) * 1991-12-18 1997-02-13 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
GB9313650D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
GB9419536D0 (en) 1994-09-28 1994-11-16 Glaxo Inc Medicaments
GB9620187D0 (en) * 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
CA2425035A1 (en) * 2000-10-09 2002-04-18 3M Innovative Properties Company Medicinal aerosol formulations
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
ATE384001T1 (de) * 2002-08-27 2008-02-15 Schering Corp Verfahren zur herstellung von dosierinhalatorformulierungen
SE0203376D0 (sv) 2002-11-15 2002-11-15 Astrazeneca Ab New process
ITMI20022674A1 (it) * 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.

Also Published As

Publication number Publication date
WO2006040598A3 (en) 2006-07-13
DE602005009012D1 (de) 2008-09-25
WO2006040598A2 (en) 2006-04-20
EP1811981A2 (de) 2007-08-01
ES2317306T3 (es) 2009-04-16
US20090297457A1 (en) 2009-12-03
CA2581999A1 (en) 2006-04-20
CA2581999C (en) 2013-04-23
AU2005293328B2 (en) 2010-09-30
US9808423B2 (en) 2017-11-07
EP1811981B1 (de) 2008-08-13
AU2005293328A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
ATE389678T1 (de) Verfahren zur herstellung von wässrigen dispersionen
DE10345043A1 (de) Mikrogel-enthaltende Zusammensetzung
ATE493425T1 (de) Verfahren zur herstellung ortho-metallierter metallverbindungen
EP3495073A3 (de) Mischung zur verwendung als bindemittel im no-bake-verfahren, reaktionsgemisch mit einer säure, verfahren zur herstellung der mischung, verfahren zum herstellen einer giessform oder eines kerns, verwendung der mischung sowie kit, der dieser mischung enthält
DE60316688D1 (de) Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon
WO2009072820A3 (en) Process for preparation of silver oxide
ATE517610T1 (de) Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform
DE602007014343D1 (de) Verfahren zur Herstellung eines dentalen Produkts
IL183013A0 (en) Structural nucleic acid guided chemical synthesis
DE602004031907D1 (de) Verfahren zur Herstellung von Nanopartikeln durch grössenspezifische Photoätzung
DE60222734D1 (de) Mikropartikel und Verfahren zur deren Herstellung
ATE484376T1 (de) Verfahren zur herstellung eines flugzeugrumps aus verbundmaterial
ATE544566T1 (de) Verfahren zur herstellung von dünne metallnanodrähte durch biotemplating
EP2282079A3 (de) Verfahren zur Herstellung einer Ausgleichswelle
WO2006114520A3 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
ATE404186T1 (de) Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden
WO2006137855A3 (en) Method for the production of polymerized nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility
DE502004006993D1 (de) Verfahren zur Herstellung von Bauteilen oder Halbzeugen, die intermetallische Titanaluminid-Legierungen enthalten, sowie mittels des Verfahrens herstellbare Bauteile
WO2005055747A3 (en) Catalysts comprising ultrafine particles
DE60316573D1 (de) Verfahren und vorrichtung für die herstellung einer ein bituminöses bindemittel enthaltenden baumischung
SA516380562B1 (ar) عملية لتحضير داي أمينات وعديد أمينات من سلسلة داي فنيل ميثان
WO2005049520A3 (en) Method for solubilizing metal oxides by surface treatment, surface treated metal oxide solutions and method for separating metal oxides
ATE418383T1 (de) Mikropellets, verfahren zur ihrer herstellung sowie deren verwendung
DE602006010542D1 (de) Verfahren zur herstellung eines nikotinzuführenden produkts
WO2011140312A3 (en) Method of making an aerosol shave composition comprising a hydrophobical agent forming at least one microdroplet

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties